Skip to main content

Table 4 Construct validity with Spearman’s rank-order correlations between ADCT total score and other patient-reported outcome measures in RELIEVE-AD

From: Validation of the Atopic Dermatitis Control Tool (ADCT©) using a longitudinal survey of biologic-treated patients with atopic dermatitis

  Baseline Month 1 Month 2 Month 3 Month 6
DLQI total score 0.543*** 0.803*** 0.828*** 0.846*** 0.812***
PGAD 0.489*** 0.734*** 0.762*** 0.758*** 0.705***
Skin pain 0.741*** 0.831*** 0.807*** 0.793*** 0.806***
WPAI-TAI 0.645*** 0.677*** 0.750*** 0.772*** 0.706***
WPAI-TWI 0.605*** 0.644*** 0.686*** 0.721*** 0.725***
  1. ***p < 0.001
  2. ADCT Atopic Dermatitis Control Tool, DLQI Dermatology Life Quality Index, PGAD Patient Global Assessment of Disease, WPAI-TAI Work Productivity and Activity Impairment - Total Activity Impairment, WPAI-TWI Work Productivity and Activity Impairment - Total Work Impairment